||The NIH has been at the forefront in the global effort to prevent the spread of ebolavirus. NIH staff were deployed in western Africa during the 2015–2016 Ebola outbreak to provide primary care to those infected, and we received Ebola patients at the NIH Clinical Center. For many years prior, however, NIH scientists have studied the natural reservoirs of emerging viruses such as ebolavirus and have elucidated the biology of ebolavirus infection, which has informed the creation of investigational Ebola vaccines.
This Demystifying Medicine lecture will convey all these elements of the NIH Ebola effort.
Daniel Chertow, head of the NIH Clinical Center Emerging Pathogens Section, was at epicenter of the 2015–2016 Ebola outbreak in Liberia and will provide a clinical field perspective.
Vincent Munster, chief of the NIAID Virus Ecology Unit, studies Ebola vectors and has camped in the jungles of Congo collecting blood samples from bats.
Nancy Sullivan, chief of the NIAID Biodefense Research Section, in the relative safety of her Bethesda-based lab, develops vaccines and antivirals against ebolavirus and other hemorrhagic fever viruses, such as Marburg and Lassa.
The Demystifying Medicine Lecture Series is designed to help bridge the gap between advances in biology and their applications to major human diseases. The lectures include presentations of patients, pathology, diagnosis, and therapy in the context of major diseases and current research. All clinicians, trainees including fellows, medical students, Ph.D. students, and other healthcare and research professionals are welcome to attend.
For more information go to https://demystifyingmedicine.od.nih.gov